HIV / AIDS
Vitamin D May Improve Bone Health in Young HIV+ People Taking Tenofovir
- Details
- Category: Bone Loss/Osteoporosis
- Published on Tuesday, 17 January 2012 00:00
Taking vitamin D supplements may help prevent hormonal changes linked to bone loss among young adults whose antiretroviral regimen includes tenofovir (Viread, also in the Truvada and Atripla combination pills), according to a recent announcement from the National Institutes of Health (NIH).
HIV Cure Working Group Calls for Abstracts for July Symposium
- Details
- Category: Search for a Cure
- Published on Tuesday, 17 January 2012 00:00
A working group under the auspices of the International AIDS Society (IAS) is developing a global scientific strategy "Towards an HIV Cure" that will be presented at a 2-day symposium in July preceding the XIX International AIDS Conference in Washington, DC.
Electrocautery Prevents Progression to Anal Cancer in HIV Positive and Negative Gay Men
- Details
- Category: Cancer/Malignancies
- Published on Tuesday, 03 January 2012 16:33
Electrocautery ablation to remove abnormal tissue significantly reduced the likelihood of progression to anal cancer for both HIV positive and HIV negative gay men with high-grade anal intraepithelial neoplasia, according to a study described in the November 30, 2011, advance online edition of the Journal of Acquired Immune Deficiency Syndromes.
Sangamo HIV Gene Therapy Trials: Until There's A Functional Cure, Treatment!
- Details
- Category: Search for a Cure
- Published on Tuesday, 17 January 2012 00:00
Signaling significant progress for research into a functional cure for HIV, Sangamo BioSciences in Richmond, Calif., has announced the start of 2 new clinical trials using SB-728-T, its HIV zinc finger gene therapy technology. Sangamo is the company furthest along in gene therapy for HIV disease.
Identification of Host Cell Proteins 'Hijacked' by HIV Offers Clues to Potential Therapies
- Details
- Category: HIV Basic Science
- Published on Tuesday, 03 January 2012 00:00
Researchers have identified interactions between all 18 HIV proteins and more than 400 host cell proteins using an in vitromass spectrometry method, as described in a pair of reports in the December 21, 2011, advance online edition of Nature.
HIV Viral Load Predicts Risk of Infection in Large Study
- Details
- Category: HIV Prevention
- Published on Tuesday, 17 January 2012 00:00
HIV RNA levels are the most significant factor predicting risk of HIV transmission, according to a study reported in the February 1, 2012, Journal of Infectious Diseases. Condom use, adult male circumcision, and concurrent sexually transmitted infections (STIs) were also important factors.
Companies Lower HIV Drug Prices for ADAP, but Many Patients Still Waiting
- Details
- Category: ADAP
- Published on Tuesday, 27 December 2011 00:00
Four pharmaceutical companies recently agreed to discount their prices on 
antiretroviral drugs for AIDS Drug Assistance Programs (ADAPs), which are under increasing pressure due to the ongoing financial crisis. More than 4000 people with HIV are currently on ADAP waiting lists, most of them in the Southeast U.S.
More Articles...
- Pediatric Dose Recommendations for Darunavir (Prezista) and Raltegravir (Isentress)
- Top 10 HIV and Hepatitis Stories of 2011
- Congress Reinstates Federal Funding Ban on Needle Exchange
- Researchers Discover Protein Key that Allows HIV to Enter Host Cell Nucleus
- Immune Deficiency Linked to Non-AIDS Cancers in People with HIV
Web Design and Development by